Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Debt / NOTE 4.000%11/1
-
Market price (% of par)
-
51.57%
-
Total 13F principal
-
$212,146,264
-
Principal change
-
+$12,592,500
-
Total reported market value
-
$118,647,578
-
Number of holders
-
20
-
Value change
-
+$5,205,374
-
Number of buys
-
3
-
Number of sells
-
7
Institutional Holders of ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1 as of Q1 2022
As of 31 Mar 2022,
ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1 was held by
20 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$212,146,264
in principal (par value) of the bond.
The largest 10 bondholders included
Pentwater Capital Management LP, Davidson Kempner Capital Management LP, WHITEBOX ADVISORS LLC, TENOR CAPITAL MANAGEMENT Co., L.P., LAZARD ASSET MANAGEMENT LLC, AMERIPRISE FINANCIAL INC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, SILVERBACK ASSET MANAGEMENT LLC, AGF INVESTMENTS INC., and Point72 Asset Management, L.P..
This page lists
20
institutional bondholders reporting positions
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.